You are here: Industry Insights > BTC

News List

Senhwa Biosciences receives ODD for Silmitasertib from FDA to treat biliary tract cancer pharmaceutical-business-review
January 21, 2022
Senhwa Biosciences has announced the receipt of Orphan Drug Designation (ODD) from the US Food and Drug Administration...
New AstraZeneca treatment for rare cancer reduces risk of death pharmatimes
January 19, 2022
Imfinzi has shown improvements in the overall survival of patients with biliary tract cancer
Merck KGaA, Darmstadt, Germany, Reports Topline Data for Bintrafusp Alfa for Biliary Tract Cancer americanpharmaceuticalreview
March 23, 2021
Merck KGaA, Darmstadt, Germany has announced topline data from the Phase II INTR@PID BTC 047 study evaluating bintrafusp alfa as a monotherapy in the second-line treatment of patients with locally advanced or metastatic biliary tract cancer (BTC) who ...
Merck Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer prnasia
March 16, 2021
Merck, a leading science and technology company, today announced topline data from the Phase II INTR@PID BTC 047 study evaluating bintrafusp alfa as a monotherapy in the second-line treatment of patients with locally advanced or metastatic biliary ...
Merck Announces Update on the INTR@PID Clinical Program Including Lung 037 Study prnasia
January 21, 2021
Merck, a leading science and technology company, announced an update on the Phase III INTR@PID Lung 037 study and the extensive INTR@PID clinical trial program for the potential first-in-class investigational bifunctional immunotherapy bintrafusp alfa ...